Epidemiology: Open Access
Open Access

James J. Collins
School of Health Sciences
Saginaw Valley State University Bay City
USA
Tel: 989-894-6687
Fax: 989-636-1875
Read Interview session with James J Collins

Dr. James Collins received his PhD in 1981 from the University of Illinois at Urbana-Champaign and is a Fellow in the American College of Epidemiology. He is currently the Director of Epidemiology at the Dow Chemical Company in Midland, Michigan. He is also an Adjunct Research Professor at the University of Pittsburgh, School of Public Health and at Saginaw Valley State University. Prior to joining Dow, he directed epidemiology programs at Solutia, Monsanto, Ford, and American Cyanamid and worked at Argonne National Laboratory. His major research interest is the impact of occupational and environmental exposures on health including exposures from dioxins, benzene, acrylonitrile, acrylamide, formaldehyde, and glutaraldehyde. He has published over 100 papers in these areas. He is currently an Officer in the American College of Epidemiology, Chairs the Scientific Advisory Panel for the National Urban Air Toxics Research Center, and is on the Editorial Boards for Environmental Health Perspectives, Journal of Environmental and Occupational Medicine and the Open Epidemiology Journal. He has also serves and has served on several science advisory committees including Houston’s Strategic Health Effects Research Panel, Oklahoma Center for Toxicology, Toxicology Excellence for Risk Assessment and several industry groups.

Impact of occupational and environmental exposures on health including exposures from dioxins, benzene, acrylonitrile, acrylamide, formaldehyde, and glutaraldehyde.

1. How many years have you been associated with the current research?
About 30 years

2. What is the research topic you are working on now?
Health effects from workplace and environmental exposures

3. What are attributes for a quality article?
Well organized, well written and brief

4. Do you have any research funding (NIH or other national funding) now?
Yes, most from industry work.

5. When did you become an editor of OMICS Journal?
2011

6. Where can the journal find the maximum scope in terms of niche?
Structuring the journal to be easily cited

7. What is your greatest career accomplishment?
Completing and publishing impactful research papers.

8. How does the published scientific content assist the potential researchers?
It tells researchers what the state of the science around their particular is and alerts to gaps in the literature that their research can fill.

9. What is the purpose of serving as an editor?
Assisting the journal in screening submittals for potentially impactful papers

10. Have you contributed any editorials or papers (any types) to OMICS Journals in the past two years?
No.

11. Do you plan to contribute any editorials or papers to OMICS Journals in the next year?
No.

12. How would you define your experience with OMICS Group?
Not much meaningful contact with the Group.

13. Your opinion on conducting Editorial Board meetings at related Conferences?
Good idea.

14. Would you recommend OMICS to your friends or colleagues?
Yes, and I have in the past.

15. How do you differentiate Epidemiology: Open Access with other journals in the field?
New journal with potential to be a good journal